Skip to main content

Incentivizing the delivery of Amarin shareholder value

41 Comments

J
john t eskridge
5 years ago

john thero is a joke!!!!! BOD needs to act!!!

J
Jay Moskowitz
5 years ago

Need a stronger legal team. Millions spent on R&D and 2 snakes get 6 patents overturned. If it was so "obvious" its competitors would have refined EPA. Shameful

P
Prasad Chivakula
6 years ago

It’s about time the company took steps to explore options to maximize share holder value , maybe selling is the best option on the table as one analyst suggested . Management was clueless, it almost seemed like the evidence did not support the claims made by Amarin in the appeals case . It took 3 judges 20 minutes ONLY!!!

T
Tomas Barreto
6 years ago

Fire John Thero, replace the BOD and find a capable CEO who can restore shareholder value.

G
Garry Stevens
6 years ago

As a shareholder of AMRN for over 5 years, I wholeheartedly agree with the points presented in this petition.

K
Kaushik Deb
6 years ago

Hohn Thero and the whole BOD should be relevant bed of their duties for the terrible performance of the stock

D
David white
6 years ago

No, no, no, and hell no.

H
Herb Novogroski
6 years ago

There is no rationale for this Board of Directors to remain in place,supporting a CEO who has no understanding of marketing and no willingness to learn! Ask one question, why, after 18 months this company has yet to hire a spokesperson? If you have a serious answer, I've got a bridge to sell you! For John Thero to seriously tell us he will "maximize" shareholder value,is laughable at best and ludicrous at worst! We have a great product marketed by an atrocious company! At some point the behavior of this board and it's continued support of Thero will be a case study taught in business schools on how to destroy a generational drug! Shame......

S
Samson Ho
6 years ago Featured

John Thero misrepresented AMRN during the patent trial and misled the public that AMRN will prevail. Meanwhile, he cashed out much of his position. John Thero is a prime example of incompetent and ill willed executive of a company.

A
Anonymous
6 years ago Featured

They don't deserve it. Destroyed share value. Create value before taking your share of it. And stop paying yourselves before turning profit. Almost 700M revenue and no profit. Disgusting

J
Jiying liu
6 years ago

Support

J
Joel Sugg
6 years ago

JT needs to be held accountable and the shareholders need something to renew hope in management with one of the greatest medicines ever discovered.

L
Laura Abner
6 years ago

Thank you

T
Thomas Miglino
6 years ago

I concur. Time for a change. Make shareholder value a reality not a talking point. And incentives must be curbed and measured against SP performance.

R
Ronda
6 years ago

Please do whatever it takes to bring us back to being a valuable company to be invested in.

T
Terri Dukes
6 years ago

Time to put an end to the mismanagement replace CEO . No compensation package till Buy-Out. Vote out JT Now.

M
Mark Sorenson
6 years ago

This longtime shareholder has heard enough from JT to know he js not the man to regain any decent value for this stock considering V is the greatest drug of the 21st century $6 SP is a disgrace!

P
Philip Remig
6 years ago

Thero, Kennedy and the rest of this leadership team must be removed and replaced. They have done nothing but erode shareholder value while lining their pockets with the $$ from free shares at public shareholders expense.

D
Dan Telford
6 years ago Featured

I lost most of my IRA savings due to the incompetent leadership. I was disappointed with his ability to generate any interest and the company while having the greatest discovery in his back pocket since statins were introduced 30+ years ago.

A
Anonymous
6 years ago

Hopefully a lot of people will sign it.